New research finds that popular weight-loss medications like Semaglutide and Liraglutide not only reduce appetite but may also significantly cut alcohol cravings and intake. Here’s what you need to know before mixing alcohol with these drugs.
A New Discovery You Didn’t Expect
Researchers studying the newest generation of weight-loss drugs found something surprising: beyond helping with appetite and weight, these drugs may also reduce the desire to drink alcohol. These medications—particularly those in the GLP-1 receptor-agonist class—include semaglutide and liraglutide.
Key Findings
-
In a real-world study in Dublin, patients using semaglutide or liraglutide for obesity saw their alcohol intake drop from ~11.3 units/week to 4.3 units/week over 4 months—a reduction of nearly two-thirds.
-
In a clinical trial of 48 adults with alcohol-use disorder, those on semaglutide drank about 40% less alcohol compared with placebo.
-
Broader health-record research found that users of these drugs had around a 50% lower rate of diagnosed alcohol-use disorder compared to matched patients not on the medication.
What This Means to Your Body
-
These drugs work by mimicking hormones that regulate appetite—but they also affect brain pathways linked to cravings and reward, which may blunt the appeal of alcohol. For someone drinking while on these medications: the intoxicating effects might be reduced, or the desire to drink may drop — meaning you might drink less, feel less drunk, or both. Anecdotally, some users report needing fewer drinks to feel effects.
-
It doesn’t mean alcohol is harmless: combining alcohol with any drug can still pose risks such as lowered blood sugar, liver strain, or impairing weight-loss results because of added calories and disrupted metabolism.